The National Institute for Communicable Diseases says it expects that the current Covid-19 vaccines will continue to protect individuals from severe disease and death after a new mutation of the virus was detected.

Published on

31 August 2021

Researchers identified a potential SARS-CoV-2 variant of interest and published the results last week. The variant was detected through genomic surveillance of the virus during the third wave of infections and was first discovered in Gauteng and Mpumalanga in May. Senior researcher at the NICD Prof Penny Moore says currently the incidence of the variant, called C.1.2 is very low.

Merentia Van Der Vent

Merentia joined the media world in 1996 and in 2001, she took her first steps in the broadcasting world. In her free time, she likes to go on adventures in the city. She also likes to learn new dances, not that she is any good at that.

Latest articles

NICD keeping a close eye on new Covid-19 variant – C.1.2 – Delta remains dominant

South Africa has confirmed another 5 644 new cases of the coronavirus, over the latest 24-hour monitoring period.

The National Institute for Communicable Diseases says it expects that the current Covid-19 vaccines will continue to protect individuals from severe disease and death after a new mutation of the virus was detected.

Latest articles

Minister Gwarube responds to McDonald’s foldable desk criticism

Joslin Smith trial: Accused Kelly Smith apparently said that Joslin made her famous

Springbok Women’s Sevens Eye Challenger Series Glory in Cape Town

Birthday twins – Ryan and Success

A look at Western Cape dam levels with winter fast-approaching

Cape Town “overrun” with cyclists

Another Traffic Fine Roadshow in Cape Town

Click here for T&cs